Kaliumklorid B. Braun

Potassium chloride, the active ingredient in Kaliumklorid B. Braun, is a potassium salt presented as an intravenous solution for intravenous use. It is employed to treat hypokalemia and potassium deficiency in patients who require rapid correction of serum potassium levels. GNH USA supplies Kaliumklorid B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumklorid B. Braun is used to address disorders of potassium balance and related clinical situations. - Hypokalemia: restores normal serum potassium concentrations and prevents cardiac complications. - Potassium deficiency: corrects electrolyte imbalance caused by inadequate dietary intake or losses. - Peri‑operative potassium loss: maintains potassium homeostasis during surgery or intensive care treatment.

Potassium chloride may cause a range of adverse reactions, most of which are related to the infusion process or excess potassium.

Common Side Effects: - Infusion site pain or irritation - Phlebitis or thrombophlebitis - Nausea or vomiting - Tingling or paresthesia - Mild hyperkalemia (transient) - Headache

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia - Cardiac arrest or sudden death - Anaphylactic or severe allergic reaction - Life‑threatening ventricular tachycardia - Pulmonary edema - Fatal electrolyte imbalance

When using Kaliumklorid B. Braun, clinicians should observe several safety measures. - Renal impairment: monitor serum potassium and renal function closely. - Cardiac disease: avoid rapid infusion rates to prevent arrhythmias. - Concomitant potassium‑sparing diuretics: increase risk of hyperkalemia; adjust dose accordingly. - Pregnancy: use only when clearly indicated after risk‑benefit assessment. - Hyperglycaemia: monitor blood glucose if administered with glucose‑containing solutions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications, altering potassium balance.

Major Interactions (Avoid): - ACE inhibitors: may cause dangerous hyperkalemia. - Angiotensin II receptor blockers (ARBs): increase risk of elevated potassium. - Potassium‑sparing diuretics (e.g., spironolactone): potentiate hyperkalemia. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): reduce renal potassium excretion. - Trimethoprim‑sulfamethoxazole: can raise serum potassium levels.

Moderate Interactions (Monitor Closely): - Digoxin: hyperkalemia may enhance digoxin toxicity. - Beta‑blockers: may mask symptoms of hypoglycaemia and affect potassium handling.